01605nam 2200385I 450 991071199410332120190225105348.0(CKB)5470000002488147(OCoLC)1088412325(EXLCZ)99547000000248814720190225d2018 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPrescription opioids: medicare needs better information to reduce the risk of harm to beneficiaries testimony before the Subcommittee on Health Care, Committee on Finance, U.S. Senate // statement of Mary Denigan-Macauley[Washington, D.C.] :United States Government Accountability Office,2018.1 online resource (13 pages) color illustrationsTestimony ;GAO-18-585T"For release on delivery, expected at 1:00 p.m. ET, Tuesday, May 29, 2018."Includes bibliographical references.Prescription opioidsOpioid abuseUnited StatesPreventionMedication abuseUnited StatesPreventionOpioid abusePrevention.Medication abusePrevention.Denigan-Macauley MaryUnited States.Congress.Senate.Committee on Finance.Subcommittee on Health Care,GPOGPOBOOK9910711994103321Prescription opioids: medicare needs better information to reduce the risk of harm to beneficiaries3503158UNINA